This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Event: 1276
Key Event Title
Lung fibrosis
Short name
Biological Context
Level of Biological Organization |
---|
Organ |
Organ term
Key Event Components
Key Event Overview
AOPs Including This Key Event
AOP Name | Role of event in AOP | Point of Contact | Author Status | OECD Status |
---|---|---|---|---|
PPARγ inactivation leading to lung fibrosis | AdverseOutcome | Jinhee Choi (send email) | Under development: Not open for comment. Do not cite | Under Development |
Binding to ACE2 leads to lung fibrosis | AdverseOutcome | Young Jun Kim (send email) | Open for comment. Do not cite | Under Development |
AT1R, lung fibrosis | AdverseOutcome | Young Jun Kim (send email) | Under development: Not open for comment. Do not cite | Under Development |
AHR activation leading to lung fibrosis via TGF-β dependent fibrosis tox path | KeyEvent | Dianke Yu (send email) | Under development: Not open for comment. Do not cite | |
AHR activation leading to lung fibrosis via IL-6 tox path | AdverseOutcome | Dianke Yu (send email) | Under development: Not open for comment. Do not cite |
Taxonomic Applicability
Life Stages
Sex Applicability
Key Event Description
This consecutive KE resulting in the acquisition of the accumulation of excess fibrous connective tissue, the adverse outcome on pulmonary fibrosis. Scar formation, the accumulation of excess fibrous connective tissue (the process called fibrosis), leads to thickening of the walls, and causes reduced oxygen supply in the blood. As a consequence patients suffer from perpetual shortness of breath.